Monthly Archives: August 2022

Resuscitation before clamping the cord, some physiologic considerations

Posted on 30 August 2022 by Keith Barrington

Delaying cord clamping until respiration is well established is a physiologically pleasing approach, and avoids the dramatic decrease in left ventricular preload, simultaneously with an increase in afterload that occurs with early clamping. But does delaying clamping during positive pressure … Continue reading →

Posted in Neonatal Research | Tagged , | 2 Comments

Is glucose gel safe? Is it necessary?

Posted on 25 August 2022 by Keith Barrington

The Auckland group has been studying the treatment and implications of neonatal hypoglycaemia for many years now, with unique high quality studies. Two of their recent publications have addressed the safety of glucose gel for hypoglycaemia, the first (St Clair … Continue reading →

Posted in Neonatal Research | Tagged , , , | 7 Comments

Anti VEGF treatment of retinopathy: and the long term?

Posted on 9 August 2022 by Keith Barrington

There remains some doubt about the impacts on cerebral development, and thus on developmental progress of anti-VEGF treated babies. It is possible that there are cerebral effects of VEGF inhibition (or interception) and it isn’t clear what the exposure of … Continue reading →

Posted in Neonatal Research | Tagged , , | Leave a comment

Anti-VEGF vs laser therapy for retinopathy, not worse, but not not worse?

Posted on 3 August 2022 by Keith Barrington

A newer anti-VEGF drug has been invented, and evaluated in retinopathy therapy. This new drug aflibercept works differently to the “-mab” drugs we have been using. Those others are monoclonal antibodies (hence mab) directed against VEGF, whereas this new stuff … Continue reading →

Posted in Neonatal Research | Tagged , | 1 Comment